What is Preclinical? (Peptide Glossary)

Preclinical research encompasses everything done before human testing: cell studies, biochemical assays, and animal models. The vast majority of compounds in the research peptide market - BPC-157, TB-500, ipamorelin, MOTS-c, epitalon - have preclinical evidence only. Their published literature consists of cell culture and rodent studies, not human trials.

Understanding this matters for interpreting claims. A vendor or forum post describing what a peptide 'does' is usually describing preclinical findings: effects observed in rats, mice, or cell cultures under laboratory conditions. These findings are scientifically real but preliminary - the history of drug development is littered with compounds that worked in animals and failed in humans.

The peptide market's most searched compounds split clearly into two evidence tiers. Preclinical-only: BPC-157, TB-500, most secretagogues. Human-trial-backed: semaglutide, tirzepatide, liraglutide, tesamorelin, bremelanotide, thymosin alpha-1. Our compound profiles label which tier each compound belongs to, because the difference is the single most important piece of research context.